The last few decades have witnessed an outstanding advancement in our understanding of
the hallmarks of endocrine cancers. This includes the epithelial to mesenchymal transition …

Metabolic reprogramming and epithelial-mesenchymal plasticity are both hallmarks of the
adaptation of cancer cells for tumor growth and progression. For metabolic changes, cancer …

Metastasis is the most frequent cause of death in cancer patients. Epithelial-to-mesenchymal
transition (EMT) is the process in which cells lose epithelial integrity and become motile, a …

Simple Summary Tumor cells display important plasticity potential. Notably, tumor cells have
the ability to change toward immature cells called cancer stem cells under the influence of …

Epithelial-mesenchymal transition (EMT) and its critical roles during cancer progression
have long been recognized and extensively reviewed. Recent studies on the generation of …

Activation of epithelial–mesenchymal transition (EMT) is thought to be an essential step for
cancer metastasis. Tumor cells undergo EMT in response to a diverse range of extra-and …

The epithelial-to-mesenchymal transition (EMT) process allows the trans-differentiation of a
cell with epithelial features into a cell with mesenchymal characteristics. This process has …

Epithelial‑mesenchymal transition (EMT) is required for the distant metastasis of tumors. The
degree of tumor malignancy increases as EMT progresses. Notably, the biology of tumor …

The epithelial–mesenchymal transition (EMT) is a developmental process that is important
for embryogenesis, wound healing, organ fibrosis, and cancer metastasis. Cancer …

Several lines of evidence indicate that during transformation epithelial cancer cells can
acquire mesenchymal features via a process called epithelial‐to‐mesenchymal transition …